TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)

SEC filing

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

TEVA · CIK 818686

4 · Aug 19, 2026 · EVP, Business Development Lippman Evan sold 18.60K shares at $36.57/share ($680.3K)

EVP, Business Development Lippman Evan sold 18.60K shares at $36.57/share ($680.3K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).